What Does TScan Therapeutics Do?

Total employees165
HeadquartersWaltham
Founded2018

TScan Therapeutics, Inc. (NASDAQ: TCRX) is a clinical-stage biopharmaceutical company focused on developing a pipeline of T-cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer. The company's lead TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. TScan is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. The company utilizes its proprietary TargetScan platform to identify novel, shared TCR targets and develop corresponding TCRs for therapeutic applications.

Where Is TScan Therapeutics's Headquarters?

TScan Therapeutics officeTScan Therapeutics officeTScan Therapeutics officeTScan Therapeutics office
*Images sourced via web search. Rights belong to original owners

HQ Function

The headquarters serves as the central hub for TScan's research and development activities, clinical operations, corporate strategy, and administrative functions.

Notable Features:

The facility likely includes state-of-the-art laboratory spaces for immunology, molecular biology, and cell therapy process development, alongside modern office environments.

Work Culture:

As a clinical-stage biotech, the work culture is likely characterized by innovation, scientific rigor, collaboration, a fast-paced environment, and a strong focus on advancing therapies for patients with cancer.

HQ Significance:

Its location in Waltham provides strategic advantages, including access to a rich talent pool from nearby academic institutions and other biotech companies, proximity to collaborators, and a supportive life sciences ecosystem.

Values Reflected in HQ: The headquarters likely reflects TScan's commitment to cutting-edge science, innovation in cancer therapy, and operational excellence in its pursuit of developing novel treatments.

Location:

TScan Therapeutics is primarily focused on its operations within the United States, with its research, development, and corporate activities centralized at its Waltham, MA headquarters. While direct international offices are not prominent, its clinical trials may involve sites and collaborators globally as its therapeutic candidates advance. The company's engagement with the international scientific and medical community also contributes to its global reach in the field of cancer immunotherapy.

Street Address:

830 Winter Street

City:

Waltham

State/Province:

Massachusetts

Country:

USA

Where Else Does TScan Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for TScan Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading TScan Therapeutics? Meet the Executive Team

As of April 2025, TScan Therapeutics' leadership includes:

Gavin MacBeath, Ph.D. - Chief Executive Officer
Jason Amello - Chief Financial Officer
Debora Barton, M.D. - Chief Medical Officer
Zoran Zdraveski, Ph.D. - Chief Scientific Officer
Robert P. Gutzwiller, Ph.D., J.D. - Chief Business Officer
Heather Maines, Ph.D. - Chief People Officer and Head of Portfolio Strategy

Who's Investing in TScan Therapeutics?

TScan Therapeutics has been backed by several prominent investors over the years, including:

Baker Bros. Advisors LP
RA Capital Management
BlackRock
Logos Capital
Viking Global Investors
GV (formerly Google Ventures)
Novartis Venture Fund
Longwood Fund
Bessemer Venture Partners
6 Dimensions Capital

What Leadership Changes Has TScan Therapeutics Seen Recently?

Hire2
Exits1

Over the past year, TScan Therapeutics has strengthened its leadership team with key appointments, particularly in finance and people operations, to support its growth and clinical development programs.

Departures

Brian M. Silver, Brian M. Silver departed from his role as Chief Financial Officer.

New Appointments:

Jason Amello, Jason Amello was appointed as Chief Financial Officer, succeeding Brian M. Silver.
Heather Maines, Ph.D., Heather Maines was appointed to the expanded role of Chief People Officer and Head of Portfolio Strategy.

What Technology (Tech Stack) Is Used byTScan Therapeutics?

Discover the tools TScan Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

TScan Therapeutics Email Formats and Examples

TScan Therapeutics most likely utilizes a common corporate email format. The most probable pattern is the first initial followed by the last name, or first name dot last name.

[first_initial][last]@tscan.com

Format

jdoe@tscan.com

Example

80%

Success rate

What's the Latest News About TScan Therapeutics?

GlobeNewswire • March 7, 2024

TScan Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

TScan Therapeutics reported its financial results for Q4 and full year 2023, highlighting progress in its clinical programs and outlining upcoming milestones for its TCR-T therapies....more

GlobeNewswire • February 22, 2024

TScan Therapeutics Presents Initial Clinical Data from Phase 1 Solid Tumor Program (TSC-100, TSC-101) at the 2024 Transplantation & Cellular Therapy Tandem Meetings

TScan presented promising initial data from its Phase 1 study of TSC-100 and TSC-101 in patients with hematologic malignancies, showing early signs of efficacy and tolerability....more

GlobeNewswire • January 4, 2024

TScan Therapeutics Announces Appointment of Heather Maines as Chief People Officer and Head of Portfolio Strategy

TScan announced the promotion of Heather Maines, Ph.D., to the newly created role of Chief People Officer and Head of Portfolio Strategy, strengthening its executive leadership team....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including TScan Therapeutics, are just a search away.